A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience - Dixon, S R; Henriques, J P; Mauri, L (JACC Cardiovasc Interv, 2009)
, et al.